Articles in Business

Zacks.com

Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog

Alexion Pharmaceuticals ( ALXN ) announced that its primary pipeline candidate asfotase alfa has been granted Orphan Drug status in Japan for treating patients suffering from hypophosphatasia, a... Read >>

Zacks.com

PartnerRe Declares New Buyback to Boost Shareholder Value - Analyst Blog

The board of PartnerRe Ltd. ( PRE ) has authorized a new stock repurchase worth 5.0 million shares. The latest sanction, to be effective immediately replaces the 6.0 million share repurchase... Read >>

Zacks.com

Roche's (RHHBY) RoActemra Gets EU Approval for Early RA - Analyst Blog

Positive news flowed in at Roche ( RHHBY ) when its rheumatoid arthritis (RA) drug RoActemra received approval from the European Commission to treat patients suffering from early RA who have... Read >>

Zacks.com

ICE to Boost Financial Data with SuperDerivatives Purchase - Analyst Blog

Intercontinental Exchange Inc. ( ICE ) announced the acquisition of Israel based financial technology service provider SuperDerivatives in an all cash deal for $350 million. The transaction is... Read >>

Zacks.com

Canadian Solar & Chinese Partners to Form Investment Fund - Analyst Blog

Ontario, Canada based solar product manufacturer Canadian Solar Inc. ( CSIQ ) announced that one of its wholly owned subsidiaries will team up with Sichuan Development Investment Management Ltd.... Read >>

Zacks.com

Broadcom Video Decoders for BrightSign 4K Digital Signage - Analyst Blog

Leading semiconductor solutions provider Broadcom Corporation ( BRCM ) recently announced that its Ultra HD system on chip (SoC) technology was selected by BrightSign LLC for its new line of 4K... Read >>

Zacks.com

TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant - Analyst Blog

TESARO, Inc. ( TSRO ) submitted a new drug application (NDA) for its pipeline candidate, oral rolapitant, to the FDA. TESARO shares gained 1.6% on the news. Rolapitant, which is a potent and... Read >>

Zacks.com

PrivateBancorp to Redeem $75M Trust Preferred Securities - Analyst Blog

PrivateBancorp, Inc. ( PVTB ) announced it decision to redeem $75.0 million of its $143.8 million issued and outstanding 10.00% trust preferred securities (TruPS). Notably the securities were... Read >>

Zacks.com

Pluristem & United Therapeutics Progress with Phase I Study - Analyst Blog

Pluristem Therapeutics Inc . ( PSTI ) announced that its licensee, United Therapeutics Corporation ( UTHR ), completed dosing of the first of the three cohorts of patients in a phase I study.... Read >>

Zacks.com

Hospira Down on Legal Blow; Court Allows Generic Precedex - Analyst Blog

Hospira ( HSP ) was dealt a legal blow by the U.S. District Court which ruled that companies like Mylan ( MYL ) are free to resume sales of their generic versions of Hospira's injectable sedative... Read >>